Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Murphy

Showing results (31-40 of 298) with videos related to

Pageof 30
Sort By:
Acta Neurologica Latinoamericana|January 1, 1979
L-dopa induced dyskinesias in asymmetrical parkinsonismM J Murphy
Health Progress (Saint Louis, Mo.)|December 11, 1987
Organizational renewal in the healthcare ministryM J Murphy
HIV Clinician|January 29, 2002
Newest protease inhibitor Kaletra has a unique profileM J Murphy
HIV Clinician|January 29, 2002
HIV/HCV co-infection has treatment implicationsM J Murphy
Faculty Notes (New Orleans, La.)|January 29, 2002
New data brings resistance testing closer to routine clinical useM J Murphy
Faculty Notes (New Orleans, La.)|January 29, 2002
Preliminary reports on interleukin-2 offer hope for better control of the HIV virusM J Murphy
Faculty Notes (New Orleans, La.)|January 29, 2002
Metabolic abnormalities are associated with HIV and treatmentM J Murphy
Journal of Chromatography|August 12, 1970
Starch-iodide as a stain for peroxidasesM J Murphy
Faculty Notes (New Orleans, La.)|May 22, 2001
Will drug resistance testing prove reliable enough to enhance HIV treatments?M J Murphy
Faculty Notes (New Orleans, La.)|May 22, 2001
Update: prophylaxis for HIV opportunistic infectionsM J Murphy
Pageof 30

Showing results (31-40 of 298) with videos related to

Sort By:
Pageof 30
Acta Neurologica Latinoamericana|January 1, 1979
L-dopa induced dyskinesias in asymmetrical parkinsonismM J Murphy
Health Progress (Saint Louis, Mo.)|December 11, 1987
Organizational renewal in the healthcare ministryM J Murphy
HIV Clinician|January 29, 2002
Newest protease inhibitor Kaletra has a unique profileM J Murphy
HIV Clinician|January 29, 2002
HIV/HCV co-infection has treatment implicationsM J Murphy
Faculty Notes (New Orleans, La.)|January 29, 2002
New data brings resistance testing closer to routine clinical useM J Murphy
Faculty Notes (New Orleans, La.)|January 29, 2002
Preliminary reports on interleukin-2 offer hope for better control of the HIV virusM J Murphy
Faculty Notes (New Orleans, La.)|January 29, 2002
Metabolic abnormalities are associated with HIV and treatmentM J Murphy
Journal of Chromatography|August 12, 1970
Starch-iodide as a stain for peroxidasesM J Murphy
Faculty Notes (New Orleans, La.)|May 22, 2001
Will drug resistance testing prove reliable enough to enhance HIV treatments?M J Murphy
Faculty Notes (New Orleans, La.)|May 22, 2001
Update: prophylaxis for HIV opportunistic infectionsM J Murphy
Pageof 30